We are live on ! Find out more
VTAK icon

Catheter Precision
VTAK

20 hedge funds and large institutions have $420K invested in Catheter Precision in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

33% more funds holding

Funds holding: 15 → 20 (+5)

0% less ownership

Funds ownership: 0% → 0% (-0%)

60% less capital invested

Capital invested by funds: $1.04M → $420K (-$620K)

Holders
20
Holders Change
+5
Holders Change %
+33.33%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
2
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$136K
2
VF
Virtu Financial
New York
+$116K
3
UBS Group
UBS Group
Switzerland
+$47.6K
4
Two Sigma Investments
Two Sigma Investments
New York
+$40.8K
5
Citigroup
Citigroup
New York
+$34K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$229K
2
Citadel Advisors
Citadel Advisors
Florida
-$68K
3
GCP
GSA Capital Partners
United Kingdom
-$56K
4
BCM
Bridgeway Capital Management
Texas
-$39K
5
XT
XTX Topco
Cayman Islands
-$21K
Name Holding Trade Value Shares
Change 		Change in
Stake
XT
26
XTX Topco
Cayman Islands
– -$21K -1 Closed
1
2

VTAK Hedge Fund Activity: Q1 2022 in Review

20 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Catheter Precision (VTAK) for Q1 2022, worth a combined $420K — down 60% from $1.04M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new VTAK positions and 5 closed out — a net gain of 5 holders — while 2 added to existing stakes and 0 trimmed.

The largest buyer was Vanguard Group, adding an estimated $136K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $229K sold.

  • 20 institutional investors held Catheter Precision (VTAK) as of Q1 2022, up from 15 in Q4 2021.
  • Funds reported $420K of Catheter Precision stock for Q1 2022, down 60% quarter-over-quarter.
  • 10 funds opened new Catheter Precision positions in Q1 2022 and 5 closed out, a net change of +5 holders.
  • The largest Catheter Precision buyer in Q1 2022 was Vanguard Group, an estimated $136K added.
  • The largest Catheter Precision seller in Q1 2022 was Renaissance Technologies, an estimated $229K sold.

Based on aggregated 13F filings for Q1 2022.